Product: The Activator

Company: Avant Bio

About the Product:

AVANT BIO is a growth equity firm focused on the enabling technologies shaping how tomorrow’s therapeutics are discovered, developed, and manufactured with an investment focus that accelerates new growth and innovation at various stages of company development. With a commitment to amplifying value and a forward-looking investment strategy, AVANT BIO is primed to unlock the full potential of therapeutic enabling technologies, TechBio, and Healthtech.

For further information, including opportunities to partner, visit www.avant.bio. Follow AVANT BIO on LinkedIn for the latest news and industry insights.

Product: ANDHealth+

Company: ANDHealth (Australia)

About the Product:

ANDHealth is Australia’s leading provider of accelerator and incubator programs for digital and connected health technology companies. Its flagship program, ANDHealth+, is an industry-led, 18-month hybrid accelerator-incubator program backed by US$36.9M (A$52.75M) Australian Government funding. ANDHealth+ identifies, selects and accelerates high-potential, globally relevant health technologies through its unique, non-profit, industry-led model. Harnessing its non-dilutive investment capabilities with world class support, ANDHealth+ de-risks digital and connected health assets for global investors and strategic partners and creates technologies which deliver measurable impact for patients, providers and payers. 

Product: Calibr-Skaggs Drug
Accelerator

Company: Calibr-Skaggs Institute for Innovative Medicines

About the Product:

The Calibr-Skaggs Drug Development Accelerator at Scripps Research transforms bold science into life-changing therapies for patients worldwide. Our mission is to tackle urgent health challenges—from cancer and autoimmune disorders to infectious and neurodegenerative diseases—through pioneering platforms like switchable CAR-T and multivalent antibody therapeutics. By uniting cutting-edge discovery with translational expertise, we accelerate breakthrough medicines from lab to clinic, ensuring innovations reach those who need them most. Through global collaborations and a relentless focus on patient outcomes, we aim to redefine what’s possible in drug development and improve lives across every corner of the world.

Product: Women’s and Children’s Health Technology Fund

Company: Cross-Border Impact Ventures

About the Product:

Cross-Border Impact Ventures is an impact venture capital firm on a mission to revolutionize venture investing in health technology. Through the Women's and Children's Health Technology Fund I and II, Cross-Border Impact Ventures invests in early-growth stage health technology companies commercializing medical devices, diagnostic tools, digital therapeutics and digital health solutions leveraging cutting-edge technologies like Artificial Intelligence (AI) and Machine Learning (ML). All innovations the Fund finances are relevant to women’s, children’s, and adolescents’ health and located in North America and Europe, with the ability to scale technologies to emerging markets. Cross-Border Impact Ventures is driven by the belief that good health should not be restricted by gender, age, race, wealth, or borders, and seeks to expand access to its portfolio’s world-class technologies inclusively and globally.

Product: Mayo Clinic / Mayo Clinic and Arizona State University Alliance for Health Care Accelerator

Company: Mayo Foundation for Medical Education and Research

About the Product:

Where Innovation Meets Impact in Health Care. The Mayo Clinic and ASU Alliance for Health Care Accelerator is a pioneering collaboration that unites the clinical excellence of Mayo Clinic with the innovation ecosystem of Arizona State University. Designed to accelerate breakthroughs in healthcare products, services and solutions, the program offers unparalleled access to clinical validation, expert mentorship, and a robust commercialization pathway. Startups benefit from direct engagement with world-renowned clinicians, regulatory experts, and venture capital networks. This accelerator transforms visionary ideas into life-saving solutions, empowering healthcare innovators to scale with purpose and precision. This one-of-a-kind collaboration exemplifies the power of interdisciplinary partnership to advance medical science and improve lives.

Product: McGill Dobson Centre for Entrepreneurship

About the Product:

The McGill Dobson Centre for Entrepreneurship is the hub of entrepreneurship at McGill University, with the mission to teach, coach, and support entrepreneurs stemming from McGill’s 11 faculties, 13 schools, and 35 research centers as they seek to build innovative companies with a purpose. With 14 learning pathways spanning four stages of the entrepreneurial journey and customized to different sectors, the Dobson Centre proudly stands as a global leader in entrepreneurship, committed to catalyzing sustainable socio-economic impact both locally and globally while addressing all 17 UN Sustainable Development Goals. With thousands of ventures supported, we count over 690 active startups who have cumulatively raised $4.6 billion, own 624 active patents, created 13,000 jobs, operate in 35 countries, and collaborate with 98 universities.

Product: The Activator

Company: Nucleate

About the Product:

The Nucleate Activator is a free, equity-free accelerator supporting scientist-entrepreneurs at the earliest stages of biotech company formation. Operating across 40 chapters in 20+ countries, the Activator provides co-founder matching, expert mentorship, hands-on workshops, and investor access to founders sourced directly from 400+ academic institutions — before most programs will engage with them. Since 2019, Activator alumni have incorporated 300+ companies, raised $670M in capital, and created 900+ jobs. Partners include Eli Lilly, Pillar VC, Genentech, and Alnylam Pharmaceuticals. The Activator removes financial and geographic barriers to biotech company creation with no fees, no equity, and no prerequisites.

Product: BioVenture eLab

Company: Weill Cornell Medicine

About the Product: